Globus Pallidus interna (GPi) Neurons
<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Globus Pallidus interna (GPi) Neurons</th>
</tr>
<tr>
<td class="label">Allen Atlas ID</td>
<td><a href="https://portal.brain-map.org/atlases-and-data/rnaseq" target="_blank">CS202210140_3525</a></td>
</tr>
<tr>
<td class="label">Lineage</td>
<td>Neuron > GABAergic > Basal ganglia output</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>GAD1, GAD2, PPP1R1B, CALB1, FOXP2</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Globus pallidus interna, Entopeduncular nucleus</td>
</tr>
<tr>
<td class="label">Disease Vulnerability</td>
<td>[Parkinson's Disease](/diseases/parkinsons-disease), [Huntington's Disease](/diseases/huntingtons), Dystonia</td>
</tr>
</table>
Globus Pallidus interna (GPi) Neurons
Introduction
Globus Pallidus Interna (Gpi) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
Globus Pallidus interna (GPi) Neurons are a specialized cell type classified within the Neuron > GABAergic > Basal ganglia output lineage. These cells are primarily found in Globus pallidus interna, Entopeduncular nucleus and are characterized by expression of marker genes including GAD1, GAD2, PPP1R1B, CALB1. They are selectively vulnerable in Parkinson's Disease, Huntington's Disease, Dystonia.
Morphology and Markers
Globus Pallidus interna (GPi) Neurons are identified by the expression of the following key marker genes:
- GAD1
- GAD2
- PPP1R1B
- CALB1
- FOXP2
These markers are used for immunohistochemical identification and single-cell RNA sequencing classification, as catalogued in the [Allen Cell Type Atlas](https://portal.brain-map.org/atlases-and-data/rnaseq).
Normal Function
Globus Pallidus interna (GPi) Neurons play essential roles in neural circuits and brain function. They are found in the following brain regions:
- Globus pallidus interna
- Entopeduncular nucleus
Their normal functions include maintaining neural circuit integrity, signal processing, and contributing to the homeostasis of their local microenvironment.
Vulnerability in Disease
Globus Pallidus interna (GPi) Neurons show selective vulnerability in the following neurodegenerative conditions:
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Huntington's Disease](/diseases/huntingtons-disease)
- Dystonia
The selective vulnerability of these cells is an active area of research, with factors including metabolic demands, calcium handling, exposure to toxic protein aggregates, and cell-autonomous gene expression programs contributing to their susceptibility.
Transcriptomic Profile
Single-cell and single-nucleus RNA sequencing studies have revealed the transcriptomic signature of Globus Pallidus interna (GPi) Neurons. Key differentially expressed genes from the Allen Cell Type Atlas and related datasets include the marker genes listed above. These transcriptomic profiles help identify subtypes and disease-associated gene expression changes.
Key Publications
[GPi neuron activity in Parkinson's disease and dystonia](https://doi.org/10.1093/brain/awaa123). Brain, 2020.
External Links
- Allen Cell Type Atlas: [https://portal.brain-map.org/atlases-and-data/rnaseq](https://portal.brain-map.org/atlases-and-data/rnaseq)
- Allen Human Brain Atlas: [https://human.brain-map.org/](https://human.brain-map.org/)
- [Cell Types Index](/cell-types)- [Diseases Index](/diseases)eases Index
- [Mechanisms Index](/mechanisms) --
Background
The study of Globus Pallidus Interna (Gpi) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
GPi in Parkinson's Disease
The Globus Pallidus interna plays a critical role in the basal ganglia motor circuit and is profoundly affected in Parkinson's disease. In the PD state, excessive inhibitory output from the GPi contributes to the characteristic motor symptoms of bradykinesia, rigidity, and tremor[@delong2007].
Hyperdirect Pathway
The hyperdirect pathway provides rapid cortical input to the subthalamic nucleus (STN) via the pontine tegmentum, bypassing the striatum. This pathway is crucial for rapid movement suppression and is altered in PD[@aron2016].
Indirect Pathway
The indirect pathway originates from striatal D2-medium spiny neurons that project to the external globus pallidus (GPe), which then projects to the subthalamic nucleus (STN). STN excitatory output drives GPi activity, increasing inhibitory projections to thalamocortical neurons[@parent1995].
GPi in Huntington's Disease
In Huntington's disease, early loss of striatal medium spiny neurons leads to decreased GPi inhibition, resulting in hyperkinetic movements (chorea, dystonia). The GPi has emerged as a target for deep brain stimulation in HD[@gonzalezalegre2021].
Therapeutic Implications
GPi Deep Brain Stimulation
High-frequency stimulation of the GPi is an established treatment for advanced Parkinson's disease and dystonia. GPi-DBS reduces motor complications and allows for reduced medication dosages[@weaver2009].
GPi Lesioning
Pallidotomy (surgical lesioning of the GPi) has been used to treat PD and dystonia, with beneficial effects on dyskinesias and motor symptoms[@fine2000].
Molecular Characteristics
GPi neurons express high levels of:
- GAD1 and GAD2 (GABA synthesizing enzymes)
- PPP1R1B (DARP-32)
- FOXP2 (transcription factor)
- Calbindin (CALB1)
References
Page auto-generated from NeuroWiki cell type database. Last updated: 2026-02-26.